The clinical laboratory Improvement amendments were established in 1988 as a set of guidelines to specify which drug tests are to be CLIA-waived tests, based on the complexity of the test performed. Tests that meet the requirements are able to be waived from regulatory oversight. Waived tests are defined as simple procedures that are cleared by the FDA for home use and labeled as easy to use and accurate enough that it’s unlikely any mistakes will occur.
